Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2013
11/05/2013CA2752865C Quickly soluble oral film dosage containing steviosides as a unpleasant taste masking agent
11/05/2013CA2605112C Solid transdermal therapeutic system comprising uv absorber
11/05/2013CA2603594C Micronized tanaproget and compositions containing same
11/05/2013CA2550718C Cohesive gels from cross-linked hyaluronan and/or hylan, their preparation and use
11/05/2013CA2535060C Osmotic delivery of therapeutic compounds by solubility enhancement
10/2013
10/31/2013WO2013163545A1 Use of n-acetylcysteine amide in the treatment of disease and injury
10/31/2013WO2013163453A1 Crystalline microspheres and the process for manufacturing the same
10/31/2013WO2013163407A1 Silk microspheres and methods for surface lubrication
10/31/2013WO2013163321A1 Singlet oxygen-labile linkers and methods of production and use thereof
10/31/2013WO2013163240A1 Center-in-shell chewable compositions with functional components
10/31/2013WO2013163234A1 Stable layer-by-layer coated particles
10/31/2013WO2013163142A1 Liquid pharmaceutical formulation containing ketorolac and tramadol
10/31/2013WO2013162990A1 System for regulating endogenous neuromodulatory agent levels
10/31/2013WO2013162828A1 Use of cpg oligonucleotides co-formulated with an antibiotic to accelarate wound healing
10/31/2013WO2013162723A1 Topical formulation compositions containing silicone based excipients to deliver actives to a substrate
10/31/2013WO2013162114A1 Sustained-release preparation using gastroretentive drug delivery system
10/31/2013WO2013162048A1 Injectable preparation
10/31/2013WO2013162041A1 Unit structure-type pharmaceutical composition for nucleic acid delivery
10/31/2013WO2013161994A1 Analgesic
10/31/2013WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same
10/31/2013WO2013161896A1 Sustained release carrier for drugs
10/31/2013WO2013161830A1 Injectable formulation
10/31/2013WO2013161823A1 Orally disintegrating tablet and method for producing same
10/31/2013WO2013161815A1 Tablet containing glutamic acid and arginine at high contents
10/31/2013WO2013161778A1 Method for producing an aqueous dispersion of drug nanoparticles and use thereof
10/31/2013WO2013161751A1 Composite particles and cell preparation prepared using same
10/31/2013WO2013161103A1 Composition having titanium oxide prevented from colour change
10/31/2013WO2013160909A1 Stable composition of fesoterodine
10/31/2013WO2013160896A1 Pomegranate oil for preventing and treating neurodegenerative diseases
10/31/2013WO2013160222A1 Treatment method for steroid responsive dermatoses
10/31/2013WO2013159861A1 Tablets with coating and the production thereof
10/31/2013WO2013159411A1 Ginkgolide injection and preparation method thereof
10/31/2013WO2013159185A1 Porphyrin-lipid stabilized nanoparticles for surface enhanced raman scattering based imaging
10/31/2013WO2013159166A1 Pharmaceutical oral dosage form for preventing vascular diseases, tablet as pharmaceutical dosage form and gelatin capsule as pharmaceutical dosage form
10/31/2013WO2013128283A3 Inhalable pharmaceutical compositions
10/31/2013WO2013120888A3 Core sheath drug delivery devices
10/31/2013WO2013114153A3 Wafer and capsule formulations with enhanced dissolution rates for fenofibrate
10/31/2013WO2013111118A3 Diaziridines for treating neurodegenerative disorders
10/31/2013WO2013111117A3 Diaziridines for treating neurodegenerative disorders
10/31/2013US20130289520 Targeted and light-activated cytosolic drug delivery
10/31/2013US20130289516 Magnetically controlled permeability membranes
10/31/2013US20130289472 Container for the generation of therapeutic microfoam
10/31/2013US20130289138 Composite material suitable for biomedical use, and method to produce it
10/31/2013US20130289135 Polymeric compositions comprising at least one volume excluding polymer
10/31/2013US20130289131 Injectable pharmaceutical compositions for the treatment of joints
10/31/2013US20130289119 Formulation comprising arginine, use and preparation thereof
10/31/2013US20130289089 Pharmaceutical Compositions for Topical Delivery of Photosensitizers and Uses Thereof
10/31/2013US20130289079 Nicotine Lozenge Composition
10/31/2013US20130288999 Compositions and methods for modulation of vascular structure and/or function
10/31/2013US20130288985 Compositions and methods of treatment of corneal endothelium disorders
10/31/2013US20130288968 Leuprolide injection
10/31/2013US20130287856 Drug Delivery Dispersion And Film Formed Therefrom
10/31/2013US20130287854 Compositions and uses
10/31/2013US20130287853 Compositions and methods for nanopolymer-based nucleic acid delivery
10/31/2013US20130287852 Compositions for nasal administration of pharmaceuticals
10/31/2013US20130287850 Formulations and methods for the controlled release of active drug substances
10/31/2013US20130287849 Formulations and methods for the controlled release of active drug substances
10/31/2013US20130287847 Solid Molecular Dispersion
10/31/2013US20130287846 Abuse-proofed oral dosage form
10/31/2013US20130287845 Oral Drug Delivery System
10/31/2013US20130287844 Agrochemical Formulation Comprising Encapsulated Pesticide
10/31/2013US20130287843 Abuse resistant capsules
10/31/2013US20130287842 Hard Capsules
10/31/2013US20130287840 Bulk Enteric Capsule Shells
10/31/2013US20130287839 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
10/31/2013US20130287834 Anti-adherent formulation including a cationic or nonionic acrylate co-polymer
10/31/2013US20130287832 Soluble needle arrays for delivery of influenza vaccines
10/31/2013US20130287823 Patch
10/31/2013US20130287817 Flowable implant with crosslinkable surface membrane
10/31/2013US20130287758 Injectable Amino-Acid Composition
10/31/2013US20130287735 High porosity materials, scaffolds, and method of making
10/31/2013US20130287729 Antigen-specific, tolerance-inducing microparticles and uses thereof
10/31/2013US20130287725 Biocompatible polymers, process for their preparation and compositions containing them
10/31/2013US20130287706 Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
10/31/2013US20130287704 Article and methods for oral self-administration of nicotine
10/31/2013US20130287698 Treatment of renal hypertension or carotid sinus syndrome with adventitial pharmaceutical sympathetic denervation or neuromodulation
10/30/2013EP2657242A2 Amphiphilic cyclic phosphazene trimer, hydrophobic pharmaceutical formulation micellized by amphiphilic cyclic phosphazene trimer, and preparation methods thereof
10/30/2013EP2656860A1 Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
10/30/2013EP2656858A1 Transpulmonary liposome for controlling drug arrival
10/30/2013EP2656857A1 Oral liquid formulation
10/30/2013EP2656856A2 Tablet formulation comprising levodopa, carbidopa, entacapone providing extended release
10/30/2013EP2656852A2 "mitseostin" pharmaceutical composition for stimulating the regeneration of supporting tissue and articular cartilage (embodiments)
10/30/2013EP2656849A1 Liposome comprising combination of chloroquine and adriamycin and preparation method thereof
10/30/2013EP2656846A1 Phosphomycin pharmaceutical composition
10/30/2013EP2656838A1 Process for manufacturing chewable dosage forms for drug delivery and products thereof
10/30/2013EP2656837A1 Lipid nanoparticles for treating ocular diseases
10/30/2013EP2656836A1 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
10/30/2013EP2656835A1 Long-lasting controlled-release liposome composition and method for producing same
10/30/2013EP2656834A1 Carotenoid oil suspension with high bioavailability and preparation method thereof
10/30/2013EP2656833A1 Crosslinked Hyaluronic Acid Compositions For Tissue Augmentation
10/30/2013EP2656832A2 Administration of cells and cellular extracts for rejuvenation
10/30/2013EP2654864A2 Method and system for drug delivery
10/30/2013EP2654817A1 Composite material suitable for biomedical use, and method to produce it
10/30/2013EP2654793A2 Methods and compositions for wound treatment
10/30/2013EP2654785A1 Enhanced immune response in bovine species
10/30/2013EP2654770A1 Pharmaceutical compositions of tenecteplase
10/30/2013EP2654747A1 Formulations of antiparasitic agents for topical administration to swine
10/30/2013EP2654746A1 Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt
10/30/2013EP2654739A2 Percutaneous absorption preparation containing rivastigmine
10/30/2013EP2654738A1 Chewing gum composition comprising cross-linked polyacrylic acid
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 2991